American Gene Technologies International Inc.

https://americangene.com/

Last activity: 09.06.2023

Active

Categories: BioTechClinicDeliveryDevelopmentDrugHealthTechHumanITPlatformTools

Developing state-of-the-art, bio-safe, high-efficiency gene therapeutics to treat HIV, cancer, and other serious human diseases.

Twitter Facebook Instagram LinkedIn Youtube Email

Likes

1.76K

Followers

8.83K

Website visits

40.6K /mo.

Mentions

Overview

Location

United States, Maryland, Rockville

Employees

11-50

Founded date

2007

Investors 1

Date	Name	Website
Sign up to see	Sign up to see	Sign up to see

Mentions in press and media 23

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Mar 1, 2023	American Gene Technologies® CEO Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award	This is a wonderful honor, made possible thanks to the stellar collaboration and unwavering commitment of my talented colleagues and team members here at American Gene. -Jeff Galvin, CEO of AGT™ ROCKVILLE, Md. (PRWEB) March 01, 2023 Jeff Ga...
Dec 23, 2022	American Gene Technologies® Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability	American Gene™ Plans for Phase 2 Trial of AGT103-T ROCKVILLE, Md., Dec. 22, 2022 /PRNewswire-PRWeb/ -- American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primar...
Dec 23, 2022	American Gene Technologies® Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability	American Gene™ Plans for Phase 2 Trial of AGT103-T ROCKVILLE, Md. (PRWEB) December 22, 2022 American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primary and secon...
Dec 22, 2022	American Gene Technologies® Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability	Our primary goal concerned safety of the cell product. Our secondary objective included measuring responses to treatment, persistence of AGT103-T in vivo, responses to HIV peptide stimulation, and ability to coordinate a killer T cell respo...
Nov 1, 2022	American Gene Technologies® Chief Medical Officer Honored by UCSF Endowment for HIV Dermatology and LGBTQ Health Research	This endowment is a testament to the hard work my colleagues and I accomplished in the 1980s during the HIV/AIDS epidemic. I’m both flattered and humbled to have my name honored with a scholarship that will better the lives of men and women...
Sep 20, 2022	American Gene Technologies® Welcomes Barry H. Wells, M.D., as Head of Business Development	I am excited to have Barry leading our investor relations and business development efforts. Barry’s combination of medical and entrepreneurial skills gives him a comprehensive understanding of our healing mission and business strategy. -Ame...
Jul 28, 2022	American Gene Technologies’ HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals	This is the next logical step in the trial’s progression. By withdrawing these patients’ antiretrovirals we can demonstrate whether our AGT103-T gene therapy leads to a cure. - Dr. Marcus A. Conant, Chief Medical Officer at American Gene Te...
Jun 21, 2022	American Gene Technologies Appoints Dr. Jeff Boyle as Chief Science Officer	Science is at the heart of everything we do at American Gene Technologies, and Dr. Boyle’s background as a science-based C-suite executive is exactly what we need to expand our R&D team and drug pipeline. -American Gene Technologies CEO...
Apr 22, 2022	American Gene Technologies Attracts Investment from Ride Wave Ventures	We’re excited and gratified that Ride Wave Ventures’ continual search for big-idea companies brought our work to its attention, and we appreciate the opportunity to collaborate and propel one another forward. -American Gene Technologies Bus...
Mar 30, 2022	American Gene Technologies Launches “The Cure Chronicles” Video Series	We believe there is hope for a cure, but we know it will take everyone working together to make it a reality and permanently end the suffering of millions of people living with HIV today. -American Gene Technologies CEO Jeff Galvin ROCKVILL...
Mar 2, 2022	American Gene Technologies Applauds the State of Maryland for Supporting Biotech Investment	We contributed to the state’s economy by growing from a handful of employees during our first round of BIITC participation to today’s approximately 50 employees, all of whom live in Maryland, spend money in Maryland, and pay taxes in Maryla...
Feb 24, 2022	American Gene Technologies Advances Closer to Demonstrating a Potential Cure for HIV	The IRB’s green light to proceed with the withdrawal study gives us the opportunity to gather additional critical efficacy data. The data we have already collected shows how close we could be to achieving our dream of curing HIV. -Dr. Marcu...
Feb 2, 2022	American Gene Technologies’ HIV Clinical Trial Shows Blood Markers of Efficacy in Two More Patients	To see these markers in all five trial participants indicates that prospects are bright for a potential one-and-done therapy to functionally cure HIV. This milestone brings us another step closer to our goal of returning people living with ...
Jan 5, 2022	American Gene Technologies Appoints Dr. Drew Palin as Business and Strategy Advisor to the CEO	Dr. Drew Palin's extensive medical and business background combined with his unique sense of entrepreneurship will greatly accelerate AGT’s mission. -AGT CEO Jeff Galvin ROCKVILLE, Md. (PRWEB) January 05, 2022 American Gene Technologies (AG...
Dec 22, 2021	American Gene Technologies’ HIV Clinical Trial Demonstrates Blood Markers of Efficacy	This is an incredibly exciting milestone in our clinical trial. We believe it is possible for a one-and-done therapy to make a person living with HIV permanently immune to HIV, and this recent data increases our optimism that we are on trac...
Dec 21, 2021	American Gene Technologies’ HIV Clinical Trial Generates Promising Efficacy Data Markers	This is an incredibly exciting milestone in our clinical trial. We believe it is possible for a one-and-done therapy to make a person living with HIV permanently immune to HIV, and this recent data increases our optimism that we are on trac...
Nov 9, 2021	American Gene Technologies Passes Major Milestone in Potential HIV Cure Clinical Trial with Third Patient Showing No Serious Adverse Effects (SAEs)	With no serious adverse effects observed in the third participant, we’re seeing a verifiable trend in the data that gives reasonable confidence that the treatment has low risk of adverse events. -AGT CEO Jeff Galvin ROCKVILLE, Md. (PRWEB) N...
Oct 18, 2021	Here are the 16 DC orgs that took home a 2021 Moxie Award	The verdict is in: DC-area companies have moxie. Sixteen local businesses were announced as 2021 Moxie Award winners last week. The awards, which are in their fourth year, honor companies, nonprofits and associations for their “boldness in ...
Sep 23, 2021	American Gene Technologies HIV Cure Clinical Trial Shows Additional Progress with No Serious Adverse Events (SAEs)	The DSMB’s green light is a huge step forward. Now that no SAEs have been observed in the second participant, we can start treating the third patient shortly and then proceed to open enrollment of additional patients soon thereafter. -AGT C...
Sep 15, 2021	American Gene Technologies Appoints Dr. Robert R. Redfield as Special Advisor to the CEO	It’s a great honor to have Bob back on board. He played a pivotal role for us as an advisor beginning in 2011, before having to resign when he was appointed as CDC director. Bob’s passion for public service is matched only by his devotion t...
Jun 21, 2021	A Window to the Past: Is the Biotech Investment Boom Going to Last?
Nov 9, 2015	New Money: These DC Companies Raised Millions This Week	Like this? Get a daily dose of D.C.-area funding news in The Beat. Sign up here. Here are all of the tech funding deals out of the Washington, D.C., area this week. We’ll be updating this post as more news comes out. Friday, November 13 Spe...

Reviews 0

FAQ about American Gene Technologies International Inc.

When was American Gene Technologies International Inc. founded?

American Gene Technologies International Inc. was founded in 2007.

What has the press written about American Gene Technologies International Inc.?

Parsers VC has collected 23 articles mentioning American Gene Technologies International Inc., among them “American Gene Technologies® CEO Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award” (Mar 1, 2023) and “American Gene Technologies® Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability” (Dec 23, 2022).

Is American Gene Technologies International Inc. still active?

Yes, American Gene Technologies International Inc. is active; its latest activity on Parsers VC dates from Jun 9, 2023.